Purchase Order HHSN271201700558P

This federal contract award, with the ID SPE2DX15D3013|SPE2DX23FURZV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $26,761.10 firm fixed-price delivery order is for the supply of CRESEMBA 186 MG CAPSULE UD 14S, a pharmaceutical product. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...

This $16,035 firm-fixed price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a New Jersey-based foreign-owned minority-owned small business. The award is for the acquisition of 2 grams of Minnelide (CAS: 1254702-87-8) and 10 grams of GNE-618 (CAS: 1362151-42-5), which are chemical compounds used to support NCATS' biomedical research programs. MedChemExpress has...

This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED for the acquisition of 15 grams of PT-2977 (CAS: 1672668-24-4) with a chemical purity exceeding 95% and enantiopurity exceeding 95%. The contract has a ceiling value of $24,800.00 and a completion date of July 8, 2020. This award is not associated with any set-aside program. Wuxi...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...

<p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $827,789 firm fixed price delivery order against its CRO Support for NCATS Drug Substance Development and Manufacture master IDIQ contract to Bachem Americas, Inc. to support the manufacture of 1 kg of CGMP L-ENK in support of the Center's drug substance development and manufacture program. Performance will take place in Torrance, California over a four-year...

Creagen Inc. was awarded a $80,000 purchase order by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a part of the National Institutes of Health (NIH), to provide services related to a library of bioactive molecules. The contract has a period of performance from July 24, 2023 through September 23, 2023 and utilizes a firm fixed price structure. To be performed in Woburn, Massachusetts, the effort aims to support the NIDDK's research programs through the...

<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by a U.S. government agency to Provid Pharmaceuticals Inc., a for-profit organization, in the amount of $199,922.00. The contract is for &quot;Medicinal Chemistry Lead Optimization&quot; research, with a completion date of June 29, 2007. The contract is a Firm Fixed Price Definitive Contract, with the place of performance being North Brunswick Township, NJ.</p>

Cyprotex US LLC was awarded a $28,100 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to provide absorption, distribution, metabolism, and excretion testing services of drug compounds. The solicitation requested absorption, distribution, metabolism, and excretion testing including solubility, parallel artificial membrane permeability assay, microsomal stability, liquid chromatography-mass...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey. The order is for photoredox chemistry discovery services with a completion date of November 4, 2022. No set-aside designation was used for this award to support the National Center's programs in translational sciences. The potential value matches the award amount to...